Skip to content

Clinical trials

Completed Phase 1 Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 1 Status: Completed Clear all

375 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20044
20053
200613
200729
200827
200929
201027
201116
201216
201320
201420
201526
201620
201714
201820
201917
202017
202115
202213
202311
20249
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed375

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wyeth is now a wholly owned subsidiary of Pfizer26
Pfizer21
Merck Sharp & Dohme LLC15
Eli Lilly and Company13
Avid Radiopharmaceuticals12
AstraZeneca11
Bristol-Myers Squibb11
Janssen Research & Development, LLC11
GlaxoSmithKline10
Institute for Neurodegenerative Disorders9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease375
Cognitive Dysfunction29
Dementia21
Huntington Disease10
Parkinson Disease10
Supranuclear Palsy, Progressive8
Neurodegenerative Diseases7
Central Nervous System Diseases5
Memory Disorders5
Tauopathies5

Trials

Showing 1 to 25 of 375. Each trial links to its page on Pharma Observatory.

275 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.